Skip to main content
. 2023 Sep 25;95(2):125–133. doi: 10.1136/jnnp-2023-331864

Figure 2.

Figure 2

Current and previous treatments. This Sankey diagram shows disease-modifying treatments used before and after autologous haematopoietic stem cell transplantation (aHSCT). Twenty-three patients had not used any disease-modifying treatment prior to aHSCT. ALZ, alemtuzumab; DMF, dimethyl fumarate; FLM, fingolimod; GLA, glatiramer acetate; IFN, interferon; IVIG, intravenous IgG; MTX, mitoxantrone; NZB, natalizumab; RTX, rituximab; TMF, teriflunomide.